BNGO - Bionano Genomics, Inc.

1.25
-0.010   -0.800%

Share volume: 97,154
Last Updated: 04-22-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.06%

PREVIOUS CLOSE
CHG
CHG%
$1.26
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 33%
Dept financing 25%
Liquidity 25%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.58%
1 Month
-14.38%
3 Months
-22.84%
6 Months
-34.55%
1 Year
-69.51%
2 Year
57.35%
Key data
Stock price
$1.25
P/E Ratio 
N/A
DAY RANGE
$1.24 - $1.30
EPS 
-$6.19
52 WEEK RANGE
$1.06 - $5.50
52 WEEK CHANGE
-$70.59
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
11.092 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
01-27-2025
NEXT EARNINGS DATE
05-07-2025
BETA 
2.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$137,745
AVERAGE 30 VOLUME 
$259,563
Company detail
CEO: Robert E. Holmlin
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping. NxClinical offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.

Recent news